Article Information
History
- October 15, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marie Malier1,2,
- Magali Court1,2,
- Khaldoun Gharzeddine1,2,3,
- Marie-Hélène Laverierre1,2,4,
- Sabrina Marsili5,6,
- Fabienne Thomas5,6,
- Thomas Decaens2,7,8,
- Gael Roth2,7,8 and
- Arnaud Millet1,2,3,#
- 1Team Mechanobiology, Immunity and Cancer, Institute for Advanced Biosciences Inserm 1209 – UMR CNRS 5309, Grenoble, France
- 2Grenoble Alpes University, Grenoble, France
- 3Research department, University Hospital Grenoble-Alpes, Grenoble, France
- 4Department of pathological anatomy and cytology, University Hospital Grenoble-Alpes, Grenoble, France
- 5CRCT Inserm U037, Toulouse University 3, Toulouse, France
- 6Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France
- 7Department of Hepatogastroenterology, University Hospital Grenoble-Alpes, Grenoble, France
- 8Team Tumor Molecular Pathology and Biomarkers, Institute for Advanced Biosciences UMR Inserm 1209 – CNRS 5309, Grenoble, France
- ↵#Corresponding author: Arnaud Millet MD PhD, Team Mechanobiology, Immunity and Cancer, Institute for Advanced Biosciences, Batiment Jean Roget 3rd floor, Domaine de la Merci 38700 La Tronche, France, e-mail: arnaud.millet{at}inserm.fr
Posted October 15, 2020.
Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer
